Publications by authors named "S Misri"

Oxidative stress, driven by reactive oxygen, nitrogen, and sulphur species (ROS, RNS, RSS), poses a significant threat to cellular integrity and human health. Generated during mitochondrial respiration, inflammation, UV exposure and pollution, these species damage cells and contribute to pathologies like cardiovascular issues, neurodegeneration, cancer, and metabolic syndromes. Lifestyle factors exert a substantial influence on oxidative stress levels, with mitochondria emerging as pivotal players in ROS generation and cellular equilibrium.

View Article and Find Full Text PDF

Small-cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with poor patient prognosis. However, the mechanisms that regulate SCLC progression and metastasis remain undefined. Here, we show that the expression of the slit guidance ligand 2 (SLIT2) tumor suppressor gene is reduced in SCLC tumors relative to adjacent normal tissue.

View Article and Find Full Text PDF

Chemotherapy forms the backbone of current treatments for many patients with advanced non-small-cell lung cancer (NSCLC). However, the survival rate is low in these patients due to the development of drug resistance, including cisplatin resistance. In this study, we developed a novel strategy to combat the growth of cisplatin-resistant (CR) NSCLC cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of S100A7, a pro-inflammatory molecule, in promoting breast cancer growth and metastasis, revealing its association with poor survival rates in patients.
  • Researchers used various human and animal models to explore the interaction between S100A7 and cPLA2, finding that S100A7 activates cPLA2 to enhance tumor progression and create an immunosuppressive environment.
  • Inhibiting cPLA2 not only reduced tumor growth but also improved the infiltration of activated immune cells, suggesting a potential therapeutic target to enhance immune response in breast cancer treatment.
View Article and Find Full Text PDF

The growing burden of obesity and incidence of the aggressive triple negative breast cancer (TNBC) is a challenge, especially amongst vulnerable populations with unmet medical needs and higher mortality from breast cancer. While some mechanisms linking obesity and TNBC have been identified, the complex nature of pathogenesis, in both obesity as well as TNBC poses a real challenge in establishing a causative role of obesity in risk of TNBC. In this review article, we discuss pathological mechanisms identified in the tumor microenvironment (TME) as well as the obese microenvironment (OME), such as inflammation, insulin resistance and survival pathways that contribute to the development and progression of TNBC.

View Article and Find Full Text PDF